保荐人（主承销商） （住所：广东省广州市黄埔区中新广州知识城腾飞一街 2 号 618 室） 二零二三年八月 关于广东利扬芯片测试股份有限公司 向不特定对象发行可转换公司债券 申请文件的第二轮审核问询函的回复报告 （修订稿） 上海证券交易所： 贵所于 2023 年 7 月 17 日出具的《关于广东利扬芯片测试股份有限公司向 不特定对象发行可转换公司债券申请文件的第二轮审核问询函》（上证科审 （再融资）〔2023〕176 号）（以下简称"第二轮审核问询函"）已收悉，广 东利扬芯片测试股份有限公司（以下简称"利扬芯片""发行人""公司"） 与保荐机构广发证券股份有限公司（以下简称"保荐机构"）、天健会计师事 务所（特殊普通合伙）（以下简称"申报会计师"）等相关方对审核问询函所 列问题进行了逐项落实、核查，现回复如下，请予审核。 除另有说明外，本审核问询函回复报告使用的简称与《广东利扬芯片测试 股份有限公司向不特定对象发行可转换公司债券募集说明书（申报稿）》中的 释义相同。 本审核问询函回复中的字体代表以下含义： | 问询函所列问题 | 黑体（加粗） | | --- | --- | | 对问询问题的回复 | 宋体 | ...

证券代码：688135 证券简称：利扬芯片 公告编号：2023-059 问询函回复（修订稿）的提示性公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 广东利扬芯片测试股份有限公司 关于公司向不特定对象发行可转换公司债券的第二轮审核 公司本次向不特定对象发行可转换公司债券事项尚需通过上交所审核，并获 得中国证券监督管理委员会（以下简称"中国证监会"）作出同意注册的决定后 方可实施，最终能否通过上交所审核，并获得中国证监会同意注册的决定及其时 间尚存在不确定性。公司将根据该事项的进展情况，严格按照有关法律法规的规 定和要求及时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 广东利扬芯片测试股份有限公司董事会 广东利扬芯片测试股份有限公司（以下简称"公司"）于 2023 年 7 月 17 日收到上海证券交易所（以下简称"上交所"）出具的《关于广东利扬芯片测试 股份有限公司向不特定对象发行可转换公司债券申请文件的第二轮审核问询函》 （上证科审（再融资）[2023]176 号）（以下简称"《问询函》"）。上交所审 核 ...

证券代码：688135 证券简称：利扬芯片 公告编号：2023-057 广东利扬芯片测试股份有限公司 第三届监事会第二十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 1、审议通过《关于选举公司第三届监事会主席的议案》 表决情况：同意3票；反对0票；弃权0票； 具体内容详见公司同日在上海证券交易所网站(www.sse.com.cn)披露的《广 东利扬芯片测试股份有限公司关于选举监事会主席的公告》。 特此公告。 广东利扬芯片测试股份有限公司监事会 2023 年 8 月 22 日 1 / 1 广东利扬芯片测试股份有限公司（以下简称"公司"或"利扬芯片"）于 2023 年 8 月 21 日召开第三届监事会第二十次会议（以下简称"本次会议"）。会议通 知已以电子通讯的方式送达各位监事，经全体监事一致同意豁免本次会议的通知 时限。本次会议由徐杰锋先生主持，并已在监事会会议上就豁免通知时限的相关 情况做出说明，与会的各位监事已知悉所议事项的相关必要信息。本次会议应到 监事 3 名，实到监事 3 ...

Financial Performance - The company's operating revenue for 2020 was CNY 252.83 million, an increase of 8.97% compared to CNY 232.01 million in 2019[22]. - The net profit attributable to shareholders for 2020 was CNY 51.95 million, a decrease of 14.61% from CNY 60.84 million in 2019[22]. - The cash flow from operating activities for 2020 was CNY 105.37 million, down 30.38% from CNY 151.35 million in 2019[22]. - The total assets at the end of 2020 were CNY 1,092.11 million, an increase of 88.29% from CNY 580.01 million at the end of 2019[22]. - The basic earnings per share for 2020 was CNY 0.49, a decrease of 19.67% compared to CNY 0.61 in 2019[23]. - The weighted average return on equity for 2020 was 10.01%, down 5.55 percentage points from 15.56% in 2019[23]. - The net profit attributable to shareholders for Q4 2020 was CNY 21.36 million, compared to CNY 20.50 million in Q2 2020[25]. - The company received government subsidies amounting to CNY 6.23 million in 2020, compared to CNY 2.25 million in 2019[27]. - The total non-recurring gains and losses for 2020 amounted to CNY 6.21 million, compared to CNY 2.23 million in 2019[28]. - The gross profit margin for the main business was 46.99%, a decrease of 6.84 percentage points year-on-year[130]. R&D and Innovation - The R&D expenditure as a percentage of operating revenue was 9.80% in 2020, up from 9.48% in 2019[24]. - The company invested a total of ¥24,782,129.58 in R&D for the year, representing a 12.69% increase from the previous year's investment of ¥21,991,301.59, with R&D expenses accounting for 9.80% of total revenue[84]. - The company added 5 invention patents and 18 utility model patents during the reporting period, bringing the total number of patents to 143[81]. - The company’s R&D investment as a percentage of revenue increased by 0.32% compared to the previous year, reflecting a commitment to innovation[84]. - The company has developed testing capabilities for emerging applications in 5G communications, sensors, and IoT, with plans to expand into AI, VR, blockchain, big data, and cloud computing testing solutions[96]. - The company emphasizes continuous innovation in technology to maintain long-term market competitiveness and enhance existing core business capabilities[96]. Operational Strategy - The company aims to enhance operational management and production efficiency to reduce costs and increase market share in the future[41]. - The company has established a production model based on order-driven production, ensuring personalized testing solutions tailored to customer needs[38]. - The company employs a sales model focused on direct sales, with a marketing center responsible for developing sales strategies and managing customer relationships[40]. - The company has established two production bases in Dongguan and Jiading, enhancing its ability to respond quickly to customer needs and maintain a competitive edge in the semiconductor industry[94][95]. - The company plans to enhance its R&D capabilities and service technology levels to increase market share in the domestic integrated circuit testing service sector[156]. - A focus on increasing investment in testing equipment and service R&D to meet future market demands is part of the operational plan[157]. Market Position and Competition - The global semiconductor market sales reached $439 billion in 2020, with a year-on-year growth of 6.5%[45]. - China's integrated circuit industry sales amounted to 884.8 billion yuan in 2020, representing a year-on-year growth of 17%[45]. - The independent third-party testing sector remains small within the overall integrated circuit industry, unable to meet the growing verification and mass production testing demands of IC design companies[56]. - The integrated circuit testing industry has a market capacity estimated between 22.67 billion and 30.23 billion yuan, with the company facing competition from various domestic and foreign players[123]. - The company has established a significant position as one of the largest independent third-party integrated circuit testing bases in China[48]. Corporate Governance and Compliance - The company has established a comprehensive corporate governance structure to enhance internal controls and protect investor rights[109]. - The company has confirmed that all board members attended the board meeting, ensuring collective responsibility for the report's accuracy[5]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties, indicating a stable financial governance structure[7]. - The actual controller and shareholders have committed to various promises, with compliance confirmed for all commitments made during the reporting period[168]. - The company has established measures to ensure compliance with information disclosure obligations during any share reduction activities[174]. Shareholder and Financial Management - The company plans to distribute a cash dividend of 3.67 RMB per 10 shares, totaling approximately 50.06 million RMB, which represents 96.36% of the net profit attributable to shareholders for 2020[5]. - The company has a share repurchase plan in place, with a commitment to repurchase shares within a specified timeframe[169]. - The company will seek acquisition opportunities in the industry to expand its scale and enhance competitiveness[160]. - The company will maintain a flexible financing strategy to effectively control capital costs and ensure sustainable development[159]. - The company reported a positive profit for the reporting period, with net income available to common shareholders being positive, but did not propose a cash profit distribution plan[167].

Financial Performance - The company's operating revenue for 2022 was CNY 452,434,959.51, representing a 15.65% increase compared to CNY 391,198,103.07 in 2021[24]. - The net profit attributable to shareholders for 2022 was CNY 32,016,650.62, a decrease of 69.75% from CNY 105,841,853.17 in 2021[24]. - The company's total assets increased by 34.43% to CNY 1,693,884,882.86 in 2022, up from CNY 1,260,044,307.09 in 2021[25]. - The basic earnings per share for 2022 was CNY 0.23, down 70.51% from CNY 0.78 in 2021[26]. - The weighted average return on equity decreased to 3.04% in 2022, down 7.45 percentage points from 10.49% in 2021[26]. - The decline in net profit was attributed to increased financial expenses due to loans taken to expand high-end testing capacity and rising share-based payment costs[98]. - The gross profit margin for testing revenue decreased by 15.41 percentage points to 37.59% compared to the previous year[124]. - The gross profit margin for chip products decreased by 15.02 percentage points to 42.08% compared to the previous year[125]. Research and Development - Research and development expenses accounted for 14.93% of operating revenue in 2022, an increase of 2.47 percentage points from 12.46% in 2021[26]. - R&D investment reached RMB 67.55 million, up 38.56% year-on-year, accounting for 14.93% of operating revenue[39]. - The company has developed core technologies in testing solutions, equipment development, and fixture design, enhancing its ability to meet diverse customer needs[69]. - The R&D team has expanded its capabilities in high-end chip testing solutions, focusing on both breadth and depth across various chip applications[75]. - The company has implemented a stock incentive plan for R&D personnel to foster sustainable talent development[74]. - The company is focusing on developing testing technologies for automotive chips, particularly in the areas of intelligent cockpit and autonomous driving[154]. Operational Strategy - The company plans to increase its total share capital from 137,249,120 shares to 199,011,224 shares by distributing 4.5 additional shares for every 10 shares held, resulting in a total increase of 61,762,104 shares[6]. - The company is enhancing its R&D capabilities by increasing investment in high-end chip testing solutions to address the needs of various application fields[27]. - The company is utilizing bank loans and financing leases to supplement its funding for expanding testing capacity[27]. - The company is expanding its high-end testing capacity to meet domestic demand for integrated circuit testing[37]. - The company is actively developing testing technologies for advanced packaging chips and sensors in various application fields[39]. - The company aims to improve operational management and production efficiency to increase market share and profitability in the high-tech service industry[52]. Corporate Governance - The audit report issued by Tianjian Accounting Firm is a standard unqualified opinion[5]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders or related parties[8]. - There are no violations of decision-making procedures regarding external guarantees[9]. - The company has not faced any issues with a majority of directors being unable to ensure the authenticity, accuracy, and completeness of the annual report[9]. - The company emphasizes that forward-looking statements regarding future plans and strategies do not constitute substantive commitments to investors[7]. - The company has established a governance structure that includes independent directors and various committees to ensure efficient operation and compliance with regulations[161]. Market Position and Risks - The company has developed into one of the largest independent third-party professional testing bases in China, achieving mass production testing for over 5,000 chip models across 44 categories[58]. - The independent third-party professional testing industry is experiencing rapid growth due to the increasing complexity of chips and the rising demand for specialized testing solutions[56]. - The company faces risks related to potential declines in consumer electronics demand, which could impact future performance[99]. - The company is exposed to risks from rising labor costs and potential disputes over property leases that could affect its operations[104][105]. - The revenue from the South China region accounted for 63.45% of total revenue, indicating a concentration risk in sales[109]. Employee and Talent Management - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to 1,202.28 million RMB[178]. - The total remuneration for core technical personnel at the end of the reporting period was 608.59 million RMB[178]. - The company has established a competitive compensation system to enhance employee motivation and ensure legal rights, tailored to different job roles[199]. - The training program focuses on improving professional and management skills, with various training initiatives including onboarding, safety education, and industry technology training[200]. Future Outlook - The company aims to enhance its R&D capabilities and increase market share in the integrated circuit testing service sector, targeting to become a leading provider in China and globally[152]. - The company plans to expand its production capacity and improve operational efficiency to maintain its competitive edge in the independent third-party testing field[153]. - The company is expanding its market presence in regions such as Asia and Europe, aiming for a market share increase of F% by the end of the next fiscal year[172]. - The company plans to issue convertible bonds to unspecified investors, with detailed proposals for the bond's terms and conditions[184].

2023 年第一季度报告 证券代码：688135 证券简称：利扬芯片 广东利扬芯片测试股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人黄江、主管会计工作负责人辜诗涛及会计机构负责人（会计主管人员）辜诗涛保证季 度报告中财务信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 项目 本报告期 本报告期比上年同 期增减变动幅度 (%) 营业收入 105,345,224.66 -4.27 归属于上市公司股东的净利润 6,301,474.05 -39.57 归属于上市公司股东的扣除非 经常性损益的净利润 3,778,110.83 -58.20 经营活动产生的现金流量净额 31,304,830.43 -20.69 基本每股收益（元/股） ...

证券代码：688135 证券简称：利扬芯片 公告编号：2023-027 广东利扬芯片测试股份有限公司 关于参加 2022 年度半导体行业专场集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议线上交流时间：2023 年 5 月 19 日（星期五）14:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 (http://roadshow.sseinfo.com) 会议召开方式：视频和线上文字互动 投资者可于 5 月 12 日(星期五)16：00 前通过公司邮箱、电话、传真等 形式将需要了解和关注的问题提前提供给公司，公司将在信息披露允许的范围内 在文字互动环节对投资者普遍关注的问题进行回答。 广东利扬芯片测试股份有限公司（以下简称"公司"）已于 2023 年 4 月 29 日在上海证券交易所网站(www.sse.com.cn)披露《2022 年年度报告》。为方便广 大投资者更加全面、深入地了解公司 2022 年度经营成果、财务状况，公司参加 ...

证券代码：688135 证券简称：利扬芯片 广东利扬芯片测试股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | |-----------------------|----------------------------------------------------------|--------------|------------------------------------------------------|----------|--------| | | 特定对象调研 | | 分析师会议 | | | | 投资者关系活动 | | | 媒体采访 □业绩说明会 | | | | 类别 | 新闻发布会 | | 路演活动 | | | | | 现场参观 | | 电话会议 | | | | | 其他 | 线上电话会议 | | | | | | 单位 | 姓名 | | 单位 | 姓名 | | | | 杨茉然 | | | 胡博清 | | | | 于畅 | | 浙商基金 | 王斌 | | 参与单位名称 | 交银施德罗 | 郭若 | | | 刘炜 | | | | 郭斐 ...

证券代码：688135 证券简称：利扬芯片 广东利扬芯片测试股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------|------------------------------|----------------------------------------------------------| | | 特定对象调研 | 分析师会议 | | 投资者关系活动 | 媒体采访 □业绩说明会 | | | 类别 | 新闻发布会 | 路演活动 | | | 现场参观 | 电话会议 | | | 其他 | | | 参与单位名称 | 详见附件 1《与会人员清单》 | | | 会议时间 2022 | 年 5 月 | | | 会议地点 网络通讯 | | | | 上市公司接待人 | 董事、董事会秘书兼财务总监 | 辜诗涛先生 | | 员姓名 | 证券事务代表 陈伟雄先生 | | | | 一、介绍公司简要情况 | | | | 二、提问环节 | | | | | （一）请问从运输成本等角度上考虑，封装测试企业是否有服务 | | | 半径的受限？ | | | | | 公司成立初期， ...

证券代码：688135 证券简称：利扬芯片 广东利扬芯片测试股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------------------|-----------------------------------------------------------------------------|----------------------------------------------------------| | 投资者关系活动 \n类别 \n | 特定对象调研 \n 媒体采访 □业绩说明会 \n 新闻发布会 \n 现场参观 \n 其他 | 分析师会议 \n 路演活动 \n 电话会议 | | | 单位 | 姓名 | | | 中园金服 | 季叶鹏 | | | 中道投资 | 卢林锋 | | | 物产中大 | 刘向豪 | | | | 张良 | | | 赛格集团 | 于海洋 | | 参与单位名称 | | 冯岩 | | | | 严建伟 | | | 华泰证券 | | | | | 刘莉 | | | | 李俊 | | | | | | | 招商资管 | 吴彤 | | | ...